Factive gemifloxacin: Phase III data

In a double-blind Phase III trial in 356 per-protocol

Read the full 95 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE